| CRISPR Medicine | This is an overview of articles on trials
This week’s IND update looks at two distinct gene-editing strategies for sickle cell disease, both of which are set to enter clinical trials soon...
Update on Allogene Therapeutics off-the-shelf CAR-T cancer therapies. This week’s gene-editing update looks at an investigational new drug (IND)...
In this week’s clinical update, we look at three clinical-stage CRISPR-engineered cell therapies that are under development for the treatment of acute...
Just 8 years after the development of CRISPR-Cas technology, Vertex Pharmaceuticals and CRISPR Therapeutics share positive clinical data for their ex...
Last week, we bought you our first IND update for a selection of gene-editing therapies currently under development for blood disorders. This week, we...